SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:
“Now available on demand!
Radioligand Therapy (RLT) is advancing rapidly, with new developments improving targeting precision and expanding treatment opportunities for patients with difficult-to-treat cancers.
This webinar, now available to watch at your convenience, provides a comprehensive overview of what cancer centres can offer today, highlights expected advances for the coming years, and discusses the most promising emerging agents in the RLT landscape.
With experts Anne-Laure Giraudet, Niklaus Schaefer, Saverio Braccini, and discussant Antoine Leimgruber.
CME accredited and free of charge.
This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its sustaining companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.”
Other articles about SPCC on OncoDaily.